MINI FUTURE LONG - GETINGE B Stock

Certificat

DE000MG1LPR4

Real-time Bid/Ask 03:23:51 2024-05-23 am EDT
0.67 EUR / 0.68 EUR +0.75% Intraday chart for MINI FUTURE LONG - GETINGE B
Current month-38.53%
1 month-36.79%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-22 0.67 -1.47%
24-05-21 0.68 0.00%
24-05-20 0.68 0.00%
24-05-17 0.68 -2.86%
24-05-16 0.7 +1.45%

Delayed Quote Börse Stuttgart

Last update May 22, 2024 at 05:22 am EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying GETINGE AB
Issuer Morgan Stanley
WKN MG1LPR
ISINDE000MG1LPR4
Date issued 2024-04-03
Strike 107.3 kr
Maturity Unlimited
Parity 10 : 1
Emission price 0.92
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.13
Lowest since issue 0.66
Spread 0.01
Spread %1.47%

Company Profile

Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications. Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%). At the end of 2021, the group had 20 production sites worldwide. Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
Sector
-
More about the company

Ratings for Getinge AB

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Getinge AB

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
185.6 SEK
Average target price
229.2 SEK
Spread / Average Target
+23.47%
Consensus